Report cover image

Anti Radiation Drugs Market, By Product Type (Radioprotectants, Radiomitigators, Others ), By Indication (Acute Radiation Syndrome, Delayed Radiation Syndrome, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), B

Publisher Coherent Market Insights
Published Oct 09, 2023
Length 160 Pages
SKU # CMI18299893

Description

Anti Radiation Drugs Market, By Product Type (Radioprotectants, Radiomitigators, Others ), By Indication (Acute Radiation Syndrome, Delayed Radiation Syndrome, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of Administration (Oral, Injectable, Others By End-User: Hospitals, Clinics, Research Institutes, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)


Anti-Radiation Drugs are pharmaceutical medications that are used to combat the harmful effects of radiation exposure in humans. Prolonged exposure to ionizing radiation can have detrimental effects on the body, leading to various health issues such as radiation sickness, cancer, and genetic mutations. As a result, the demand for anti-radiation drugs has been increasing in recent years.

These drugs work by protecting the body's cells and DNA from the damaging effects of radiation. They aid in reducing the risk of radiation-induced illnesses and improving the chances of survival for individuals exposed to radiation. Anti-radiation drugs can be used as preventive measures for people working in industries that involve radiation exposure, as well as for individuals in areas prone to natural radiation.

Market Dynamics:

The global Anti-Radiation Drugs market is projected to witness significant growth in the coming years. The market is primarily driven by the increasing prevalence of cancer and the growing adoption of radiation therapy in cancer treatment. Additionally, the rise in the number of nuclear power plants, along with the potential risk of radiation leaks, is further propelling the demand for anti-radiation drugs.

On the other hand, there are certain factors that may restrain market growth. These include the high cost of anti-radiation drugs and the stringent regulatory requirements for drug approval. Moreover, the lack of awareness about the availability and benefits of these drugs among healthcare professionals and the general population could hinder market growth.

Despite the challenges, the market presents numerous opportunities for growth. The increasing investment in research and development activities to develop new and improved anti-radiation drugs is one such opportunity. Additionally, the rising demand for personalized medicine and the growing focus on precision healthcare are expected to drive market growth further.

Key Features of the Study:
  • This report provides in-depth analysis of the global Anti Radiation Drugs market, including market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), with 2022 as the base year.
  • It elucidates potential revenue opportunities across different market segments and explains attractive investment propositions.
  • The study provides key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and the competitive strategies adopted by key players.
  • Key players in the global Anti radiation drugs market are profiled based on parameters such as company highlights, product portfolio, financial performance, and strategies.
  • The report includes prominent companies such as RxBio Inc., Annova Chem Inc., Medicom Healthcare Ltd., Onconova Therapeutics, Genome Protection Inc., Grace Therapeutics LLC, Amgen Inc., Partner Therapeutics Inc., Jubilant Life Sciences Ltd., Cipla Inc., Stium Inc., Soligenix Inc., Aeolus Pharmaceuticals, PharmaIN Corp, and Immune Modulators Inc.
  • Insights from this report will enable marketers and management authorities to make informed decisions regarding product launches, upgrades, market expansion, and marketing tactics.
  • The report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders can benefit from the various strategy matrices used in analyzing the global Anti radiation drugs market, facilitating ease in decision-making.
Anti Radiation Drugs Market Segmentation:
  • By Product Type
  • Radioprotectants
  • Radiomitigators
  • Others
  • By Indication
  • Acute Radiation Syndrome
  • Delayed Radiation Syndrome
  • Others
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Route of Administration
  • Oral
  • Injectable
  • Others
  • By End User
  • Hospitals
  • Clinics
  • Research Institutes
  • Others
  • By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Top companies in Anti Radiation Drugs Market
  • Amgen Inc.
  • Partner Therapeutics Inc.
  • Jubilant Life Sciences Ltd.
  • Cipla Inc.
  • Stium Inc.
  • RxBio Inc.
  • Soligenix Inc.
  • Aeolus Pharmaceuticals
  • PharmaIN Corp
  • Immune Modulators Inc.
  • Annova Chem Inc.
  • Medicom Healthcare Ltd.
  • Onconova Therapeutics
  • Genome Protection Inc.
  • Grace Therapeutics LLC
  • Coro Global Inc.
  • Panacea Biotec Ltd
  • Curophen Therapeutics Pvt Ltd
  • Otsuka Holdings Co Ltd
  • Preventive Oncology International Inc.

Table of Contents

160 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Indication
Market Snapshot, By Distribution Channel
Market Snapshot, By Route of Administration
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing incidence of cancer globally
Restraints
Challenges in clinical evaluation of anti-radiation drugs
Opportunities
Development of effective countermeasures for emerging radiological threats
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Anti-Radiation Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Anti-Radiation Drugs Market , By Product Type, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Radioprotectants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Radiomitigators
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
6. Anti-Radiation Drugs Market , By Indication, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018– 2030
Segment Trends
Acute Radiation Syndrome
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Delayed Radiation Syndrome
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
7. Anti-Radiation Drugs Market , By Distribution Channel, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018– 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
8. Anti-Radiation Drugs Market , By Route of Administration, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018– 2030
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
9. Anti-Radiation Drugs Market , By End User, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018– 2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
10. Anti-Radiation Drugs Market , By Region, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2018– 2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
Latin America
Middle East & Africa
11. Competitive Landscape
Amgen Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Partner Therapeutics Inc.
Jubilant Life Sciences Ltd.
Cipla Inc.
Stium Inc.
RxBio Inc.
Soligenix Inc.
Aeolus Pharmaceuticals
PharmaIN Corp
Immune Modulators Inc.
Annova Chem Inc.
Medicom Healthcare Ltd.
Onconova Therapeutics
Genome Protection Inc.
Grace Therapeutics LLC
Coro Global Inc.
Panacea Biotec Ltd
Curophen Therapeutics Pvt Ltd
Otsuka Holdings Co Ltd
Preventive Oncology International Inc.
Analyst Views
12. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on “Anti-Radiation Drugs Market” - Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us